nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Mometasone—systemic scleroderma	0.22	0.325	CbGbCtD
Sitagliptin—ABCB1—Lisinopril—systemic scleroderma	0.101	0.148	CbGbCtD
Sitagliptin—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0875	0.129	CbGbCtD
Sitagliptin—ABCB1—Captopril—systemic scleroderma	0.0753	0.111	CbGbCtD
Sitagliptin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0593	0.0875	CbGbCtD
Sitagliptin—ABCB1—Prednisone—systemic scleroderma	0.0474	0.0699	CbGbCtD
Sitagliptin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0355	0.0524	CbGbCtD
Sitagliptin—CYP3A4—Prednisone—systemic scleroderma	0.0284	0.0419	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—systemic scleroderma	0.0238	0.0351	CbGbCtD
Sitagliptin—Renal failure acute—Methotrexate—systemic scleroderma	0.000409	0.00127	CcSEcCtD
Sitagliptin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000407	0.00126	CcSEcCtD
Sitagliptin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000404	0.00125	CcSEcCtD
Sitagliptin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000403	0.00125	CcSEcCtD
Sitagliptin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00124	CcSEcCtD
Sitagliptin—Cough—Lisinopril—systemic scleroderma	0.0004	0.00124	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000398	0.00123	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000396	0.00123	CcSEcCtD
Sitagliptin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000395	0.00123	CcSEcCtD
Sitagliptin—Tension—Mycophenolate mofetil—systemic scleroderma	0.000394	0.00122	CcSEcCtD
Sitagliptin—Insomnia—Leflunomide—systemic scleroderma	0.000393	0.00122	CcSEcCtD
Sitagliptin—Myalgia—Lisinopril—systemic scleroderma	0.00039	0.00121	CcSEcCtD
Sitagliptin—Arthralgia—Lisinopril—systemic scleroderma	0.00039	0.00121	CcSEcCtD
Sitagliptin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00121	CcSEcCtD
Sitagliptin—Anxiety—Lisinopril—systemic scleroderma	0.000389	0.0012	CcSEcCtD
Sitagliptin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000388	0.0012	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000387	0.0012	CcSEcCtD
Sitagliptin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000386	0.0012	CcSEcCtD
Sitagliptin—Discomfort—Lisinopril—systemic scleroderma	0.000385	0.00119	CcSEcCtD
Sitagliptin—Dyspepsia—Leflunomide—systemic scleroderma	0.000383	0.00119	CcSEcCtD
Sitagliptin—Pancreatitis—Prednisone—systemic scleroderma	0.000383	0.00119	CcSEcCtD
Sitagliptin—Vomiting—Mometasone—systemic scleroderma	0.000382	0.00118	CcSEcCtD
Sitagliptin—Dry mouth—Lisinopril—systemic scleroderma	0.000381	0.00118	CcSEcCtD
Sitagliptin—Feeling abnormal—Azathioprine—systemic scleroderma	0.00038	0.00118	CcSEcCtD
Sitagliptin—Rash—Mometasone—systemic scleroderma	0.000379	0.00117	CcSEcCtD
Sitagliptin—Asthenia—Captopril—systemic scleroderma	0.000379	0.00117	CcSEcCtD
Sitagliptin—Dermatitis—Mometasone—systemic scleroderma	0.000379	0.00117	CcSEcCtD
Sitagliptin—Decreased appetite—Leflunomide—systemic scleroderma	0.000378	0.00117	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000378	0.00117	CcSEcCtD
Sitagliptin—Osteoarthritis—Methotrexate—systemic scleroderma	0.000377	0.00117	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000377	0.00117	CcSEcCtD
Sitagliptin—Headache—Mometasone—systemic scleroderma	0.000376	0.00117	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000376	0.00116	CcSEcCtD
Sitagliptin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000375	0.00116	CcSEcCtD
Sitagliptin—Fatigue—Leflunomide—systemic scleroderma	0.000375	0.00116	CcSEcCtD
Sitagliptin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000374	0.00116	CcSEcCtD
Sitagliptin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000372	0.00115	CcSEcCtD
Sitagliptin—Pain—Leflunomide—systemic scleroderma	0.000372	0.00115	CcSEcCtD
Sitagliptin—Constipation—Leflunomide—systemic scleroderma	0.000372	0.00115	CcSEcCtD
Sitagliptin—Infection—Lisinopril—systemic scleroderma	0.000371	0.00115	CcSEcCtD
Sitagliptin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000369	0.00114	CcSEcCtD
Sitagliptin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00114	CcSEcCtD
Sitagliptin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000365	0.00113	CcSEcCtD
Sitagliptin—Abdominal pain—Azathioprine—systemic scleroderma	0.000364	0.00113	CcSEcCtD
Sitagliptin—Skin disorder—Lisinopril—systemic scleroderma	0.000363	0.00113	CcSEcCtD
Sitagliptin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00112	CcSEcCtD
Sitagliptin—Diarrhoea—Captopril—systemic scleroderma	0.000361	0.00112	CcSEcCtD
Sitagliptin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000361	0.00112	CcSEcCtD
Sitagliptin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00036	0.00112	CcSEcCtD
Sitagliptin—Erectile dysfunction—Prednisone—systemic scleroderma	0.00036	0.00111	CcSEcCtD
Sitagliptin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000358	0.00111	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000358	0.00111	CcSEcCtD
Sitagliptin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000358	0.00111	CcSEcCtD
Sitagliptin—Nausea—Mometasone—systemic scleroderma	0.000357	0.00111	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000356	0.0011	CcSEcCtD
Sitagliptin—Weight increased—Prednisone—systemic scleroderma	0.000355	0.0011	CcSEcCtD
Sitagliptin—Pain—Mycophenolic acid—systemic scleroderma	0.000355	0.0011	CcSEcCtD
Sitagliptin—Constipation—Mycophenolic acid—systemic scleroderma	0.000355	0.0011	CcSEcCtD
Sitagliptin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000352	0.00109	CcSEcCtD
Sitagliptin—Cough—Mycophenolate mofetil—systemic scleroderma	0.00035	0.00109	CcSEcCtD
Sitagliptin—Dizziness—Captopril—systemic scleroderma	0.000349	0.00108	CcSEcCtD
Sitagliptin—Depression—Prednisone—systemic scleroderma	0.000347	0.00108	CcSEcCtD
Sitagliptin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00107	CcSEcCtD
Sitagliptin—Urticaria—Leflunomide—systemic scleroderma	0.000346	0.00107	CcSEcCtD
Sitagliptin—Abdominal pain—Leflunomide—systemic scleroderma	0.000344	0.00107	CcSEcCtD
Sitagliptin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000342	0.00106	CcSEcCtD
Sitagliptin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00106	CcSEcCtD
Sitagliptin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00106	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000341	0.00106	CcSEcCtD
Sitagliptin—Breast disorder—Methotrexate—systemic scleroderma	0.000341	0.00106	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000341	0.00106	CcSEcCtD
Sitagliptin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00106	CcSEcCtD
Sitagliptin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000339	0.00105	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000339	0.00105	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000339	0.00105	CcSEcCtD
Sitagliptin—Insomnia—Lisinopril—systemic scleroderma	0.000338	0.00105	CcSEcCtD
Sitagliptin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000338	0.00105	CcSEcCtD
Sitagliptin—Vomiting—Captopril—systemic scleroderma	0.000336	0.00104	CcSEcCtD
Sitagliptin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00104	CcSEcCtD
Sitagliptin—Rash—Captopril—systemic scleroderma	0.000333	0.00103	CcSEcCtD
Sitagliptin—Dermatitis—Captopril—systemic scleroderma	0.000332	0.00103	CcSEcCtD
Sitagliptin—Somnolence—Lisinopril—systemic scleroderma	0.000332	0.00103	CcSEcCtD
Sitagliptin—Headache—Captopril—systemic scleroderma	0.000331	0.00103	CcSEcCtD
Sitagliptin—Dyspepsia—Lisinopril—systemic scleroderma	0.000329	0.00102	CcSEcCtD
Sitagliptin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000328	0.00102	CcSEcCtD
Sitagliptin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000327	0.00102	CcSEcCtD
Sitagliptin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00101	CcSEcCtD
Sitagliptin—Decreased appetite—Lisinopril—systemic scleroderma	0.000325	0.00101	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000323	0.001	CcSEcCtD
Sitagliptin—Fatigue—Lisinopril—systemic scleroderma	0.000322	0.000999	CcSEcCtD
Sitagliptin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000996	CcSEcCtD
Sitagliptin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00032	0.000994	CcSEcCtD
Sitagliptin—Pancreatitis—Methotrexate—systemic scleroderma	0.00032	0.000992	CcSEcCtD
Sitagliptin—Pain—Lisinopril—systemic scleroderma	0.00032	0.000991	CcSEcCtD
Sitagliptin—Constipation—Lisinopril—systemic scleroderma	0.00032	0.000991	CcSEcCtD
Sitagliptin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000986	CcSEcCtD
Sitagliptin—Diarrhoea—Azathioprine—systemic scleroderma	0.000315	0.000977	CcSEcCtD
Sitagliptin—Nausea—Captopril—systemic scleroderma	0.000313	0.000972	CcSEcCtD
Sitagliptin—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000313	0.00097	CcSEcCtD
Sitagliptin—Asthenia—Leflunomide—systemic scleroderma	0.000312	0.000968	CcSEcCtD
Sitagliptin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000308	0.000955	CcSEcCtD
Sitagliptin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000307	0.000952	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000306	0.000948	CcSEcCtD
Sitagliptin—Dizziness—Azathioprine—systemic scleroderma	0.000305	0.000945	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000303	0.00094	CcSEcCtD
Sitagliptin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.0003	0.000932	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000925	CcSEcCtD
Sitagliptin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000298	0.000923	CcSEcCtD
Sitagliptin—Diarrhoea—Leflunomide—systemic scleroderma	0.000298	0.000923	CcSEcCtD
Sitagliptin—Urticaria—Lisinopril—systemic scleroderma	0.000297	0.000921	CcSEcCtD
Sitagliptin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000919	CcSEcCtD
Sitagliptin—Abdominal pain—Lisinopril—systemic scleroderma	0.000295	0.000916	CcSEcCtD
Sitagliptin—Vomiting—Azathioprine—systemic scleroderma	0.000293	0.000908	CcSEcCtD
Sitagliptin—Pneumonia—Methotrexate—systemic scleroderma	0.000293	0.000907	CcSEcCtD
Sitagliptin—Eye disorder—Prednisone—systemic scleroderma	0.000292	0.000905	CcSEcCtD
Sitagliptin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000291	0.000903	CcSEcCtD
Sitagliptin—Infestation—Methotrexate—systemic scleroderma	0.000291	0.000902	CcSEcCtD
Sitagliptin—Infestation NOS—Methotrexate—systemic scleroderma	0.000291	0.000902	CcSEcCtD
Sitagliptin—Rash—Azathioprine—systemic scleroderma	0.00029	0.000901	CcSEcCtD
Sitagliptin—Dermatitis—Azathioprine—systemic scleroderma	0.00029	0.0009	CcSEcCtD
Sitagliptin—Depression—Methotrexate—systemic scleroderma	0.00029	0.000899	CcSEcCtD
Sitagliptin—Headache—Azathioprine—systemic scleroderma	0.000289	0.000895	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000288	0.000894	CcSEcCtD
Sitagliptin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000894	CcSEcCtD
Sitagliptin—Dizziness—Leflunomide—systemic scleroderma	0.000288	0.000892	CcSEcCtD
Sitagliptin—Renal failure—Methotrexate—systemic scleroderma	0.000286	0.000887	CcSEcCtD
Sitagliptin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000883	CcSEcCtD
Sitagliptin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000284	0.00088	CcSEcCtD
Sitagliptin—Angiopathy—Prednisone—systemic scleroderma	0.000283	0.000879	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000877	CcSEcCtD
Sitagliptin—Immune system disorder—Prednisone—systemic scleroderma	0.000282	0.000875	CcSEcCtD
Sitagliptin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000868	CcSEcCtD
Sitagliptin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000868	CcSEcCtD
Sitagliptin—Vomiting—Leflunomide—systemic scleroderma	0.000277	0.000858	CcSEcCtD
Sitagliptin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000275	0.000854	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000275	0.000853	CcSEcCtD
Sitagliptin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000274	0.000851	CcSEcCtD
Sitagliptin—Rash—Leflunomide—systemic scleroderma	0.000274	0.00085	CcSEcCtD
Sitagliptin—Dermatitis—Leflunomide—systemic scleroderma	0.000274	0.00085	CcSEcCtD
Sitagliptin—Mental disorder—Prednisone—systemic scleroderma	0.000274	0.000849	CcSEcCtD
Sitagliptin—Nausea—Azathioprine—systemic scleroderma	0.000274	0.000848	CcSEcCtD
Sitagliptin—Headache—Leflunomide—systemic scleroderma	0.000272	0.000845	CcSEcCtD
Sitagliptin—Malnutrition—Prednisone—systemic scleroderma	0.000272	0.000843	CcSEcCtD
Sitagliptin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000837	CcSEcCtD
Sitagliptin—Asthenia—Lisinopril—systemic scleroderma	0.000268	0.000832	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00083	CcSEcCtD
Sitagliptin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000264	0.000818	CcSEcCtD
Sitagliptin—Rash—Mycophenolic acid—systemic scleroderma	0.000262	0.000811	CcSEcCtD
Sitagliptin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000261	0.000811	CcSEcCtD
Sitagliptin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000807	CcSEcCtD
Sitagliptin—Headache—Mycophenolic acid—systemic scleroderma	0.00026	0.000806	CcSEcCtD
Sitagliptin—Pharyngitis—Methotrexate—systemic scleroderma	0.000259	0.000804	CcSEcCtD
Sitagliptin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000803	CcSEcCtD
Sitagliptin—Nausea—Leflunomide—systemic scleroderma	0.000258	0.000801	CcSEcCtD
Sitagliptin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000258	0.0008	CcSEcCtD
Sitagliptin—Vision blurred—Prednisone—systemic scleroderma	0.000256	0.000795	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—systemic scleroderma	0.000256	0.000794	CcSEcCtD
Sitagliptin—Diarrhoea—Lisinopril—systemic scleroderma	0.000256	0.000793	CcSEcCtD
Sitagliptin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000252	0.000783	CcSEcCtD
Sitagliptin—Angioedema—Prednisone—systemic scleroderma	0.000249	0.000771	CcSEcCtD
Sitagliptin—Dizziness—Lisinopril—systemic scleroderma	0.000247	0.000766	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000247	0.000766	CcSEcCtD
Sitagliptin—Nausea—Mycophenolic acid—systemic scleroderma	0.000246	0.000764	CcSEcCtD
Sitagliptin—Malaise—Prednisone—systemic scleroderma	0.000245	0.000761	CcSEcCtD
Sitagliptin—Vertigo—Prednisone—systemic scleroderma	0.000244	0.000758	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—systemic scleroderma	0.000244	0.000757	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000242	0.000752	CcSEcCtD
Sitagliptin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000748	CcSEcCtD
Sitagliptin—Vomiting—Lisinopril—systemic scleroderma	0.000238	0.000737	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—systemic scleroderma	0.000237	0.000735	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—systemic scleroderma	0.000236	0.000731	CcSEcCtD
Sitagliptin—Rash—Lisinopril—systemic scleroderma	0.000236	0.000731	CcSEcCtD
Sitagliptin—Dermatitis—Lisinopril—systemic scleroderma	0.000235	0.00073	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000235	0.00073	CcSEcCtD
Sitagliptin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000729	CcSEcCtD
Sitagliptin—Hypertension—Prednisone—systemic scleroderma	0.000235	0.000728	CcSEcCtD
Sitagliptin—Headache—Lisinopril—systemic scleroderma	0.000234	0.000726	CcSEcCtD
Sitagliptin—Arthralgia—Prednisone—systemic scleroderma	0.000232	0.000718	CcSEcCtD
Sitagliptin—Myalgia—Prednisone—systemic scleroderma	0.000232	0.000718	CcSEcCtD
Sitagliptin—Anxiety—Prednisone—systemic scleroderma	0.000231	0.000716	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00023	0.000713	CcSEcCtD
Sitagliptin—Discomfort—Prednisone—systemic scleroderma	0.000229	0.000709	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—systemic scleroderma	0.000229	0.000709	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—systemic scleroderma	0.000227	0.000705	CcSEcCtD
Sitagliptin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000695	CcSEcCtD
Sitagliptin—Nausea—Lisinopril—systemic scleroderma	0.000222	0.000688	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000222	0.000688	CcSEcCtD
Sitagliptin—Infection—Prednisone—systemic scleroderma	0.000221	0.000684	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—systemic scleroderma	0.00022	0.000682	CcSEcCtD
Sitagliptin—Nervous system disorder—Prednisone—systemic scleroderma	0.000218	0.000675	CcSEcCtD
Sitagliptin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000672	CcSEcCtD
Sitagliptin—Skin disorder—Prednisone—systemic scleroderma	0.000216	0.000669	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—systemic scleroderma	0.000214	0.000664	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000211	0.000654	CcSEcCtD
Sitagliptin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000646	CcSEcCtD
Sitagliptin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00064	CcSEcCtD
Sitagliptin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00064	CcSEcCtD
Sitagliptin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000636	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—systemic scleroderma	0.000205	0.000636	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—systemic scleroderma	0.000204	0.000633	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000202	0.000627	CcSEcCtD
Sitagliptin—Insomnia—Prednisone—systemic scleroderma	0.000201	0.000623	CcSEcCtD
Sitagliptin—Cough—Methotrexate—systemic scleroderma	0.000198	0.000615	CcSEcCtD
Sitagliptin—Dyspepsia—Prednisone—systemic scleroderma	0.000195	0.000606	CcSEcCtD
Sitagliptin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000603	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—systemic scleroderma	0.000194	0.0006	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—systemic scleroderma	0.000194	0.0006	CcSEcCtD
Sitagliptin—Decreased appetite—Prednisone—systemic scleroderma	0.000193	0.000598	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000192	0.000596	CcSEcCtD
Sitagliptin—Fatigue—Prednisone—systemic scleroderma	0.000191	0.000593	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—systemic scleroderma	0.000191	0.000593	CcSEcCtD
Sitagliptin—Constipation—Prednisone—systemic scleroderma	0.00019	0.000589	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000186	0.000575	CcSEcCtD
Sitagliptin—Infection—Methotrexate—systemic scleroderma	0.000184	0.000572	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisone—systemic scleroderma	0.000183	0.000567	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000182	0.000564	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000182	0.000563	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—systemic scleroderma	0.00018	0.000559	CcSEcCtD
Sitagliptin—Urticaria—Prednisone—systemic scleroderma	0.000176	0.000547	CcSEcCtD
Sitagliptin—Abdominal pain—Prednisone—systemic scleroderma	0.000175	0.000544	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000169	0.000524	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—systemic scleroderma	0.000168	0.00052	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—systemic scleroderma	0.000165	0.000511	CcSEcCtD
Sitagliptin—Hypersensitivity—Prednisone—systemic scleroderma	0.000164	0.000507	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—systemic scleroderma	0.000163	0.000506	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—systemic scleroderma	0.000161	0.0005	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00016	0.000497	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—systemic scleroderma	0.00016	0.000496	CcSEcCtD
Sitagliptin—Asthenia—Prednisone—systemic scleroderma	0.000159	0.000494	CcSEcCtD
Sitagliptin—Pain—Methotrexate—systemic scleroderma	0.000159	0.000492	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000153	0.000474	CcSEcCtD
Sitagliptin—Diarrhoea—Prednisone—systemic scleroderma	0.000152	0.000471	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000152	0.00047	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—systemic scleroderma	0.000147	0.000457	CcSEcCtD
Sitagliptin—Dizziness—Prednisone—systemic scleroderma	0.000147	0.000455	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—systemic scleroderma	0.000147	0.000455	CcSEcCtD
Sitagliptin—Vomiting—Prednisone—systemic scleroderma	0.000141	0.000438	CcSEcCtD
Sitagliptin—Rash—Prednisone—systemic scleroderma	0.00014	0.000434	CcSEcCtD
Sitagliptin—Dermatitis—Prednisone—systemic scleroderma	0.00014	0.000434	CcSEcCtD
Sitagliptin—Headache—Prednisone—systemic scleroderma	0.000139	0.000431	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000137	0.000424	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—systemic scleroderma	0.000133	0.000413	CcSEcCtD
Sitagliptin—Nausea—Prednisone—systemic scleroderma	0.000132	0.000409	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—systemic scleroderma	0.000127	0.000394	CcSEcCtD
Sitagliptin—Dizziness—Methotrexate—systemic scleroderma	0.000123	0.00038	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—systemic scleroderma	0.000118	0.000366	CcSEcCtD
Sitagliptin—Rash—Methotrexate—systemic scleroderma	0.000117	0.000363	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—systemic scleroderma	0.000117	0.000362	CcSEcCtD
Sitagliptin—Headache—Methotrexate—systemic scleroderma	0.000116	0.00036	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—systemic scleroderma	0.00011	0.000342	CcSEcCtD
